467 related articles for article (PubMed ID: 25605764)
1. Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.
Tiner BL; Sha J; Kirtley ML; Erova TE; Popov VL; Baze WB; van Lier CJ; Ponnusamy D; Andersson JA; Motin VL; Chauhan S; Chopra AK
Infect Immun; 2015 Apr; 83(4):1318-38. PubMed ID: 25605764
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.
Tiner BL; Sha J; Ponnusamy D; Baze WB; Fitts EC; Popov VL; van Lier CJ; Erova TE; Chopra AK
Clin Vaccine Immunol; 2015 Dec; 22(12):1255-68. PubMed ID: 26446423
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the Braun lipoprotein-encoding gene and altering the function of lipopolysaccharide attenuate the plague bacterium.
Sha J; Kirtley ML; van Lier CJ; Wang S; Erova TE; Kozlova EV; Cao A; Cong Y; Fitts EC; Rosenzweig JA; Chopra AK
Infect Immun; 2013 Mar; 81(3):815-28. PubMed ID: 23275092
[TBL] [Abstract][Full Text] [Related]
4. High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.
Ponnusamy D; Fitts EC; Sha J; Erova TE; Kozlova EV; Kirtley ML; Tiner BL; Andersson JA; Chopra AK
Infect Immun; 2015 May; 83(5):2065-81. PubMed ID: 25754198
[TBL] [Abstract][Full Text] [Related]
5. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.
Sha J; Agar SL; Baze WB; Olano JP; Fadl AA; Erova TE; Wang S; Foltz SM; Suarez G; Motin VL; Chauhan S; Klimpel GR; Peterson JW; Chopra AK
Infect Immun; 2008 Apr; 76(4):1390-409. PubMed ID: 18227160
[TBL] [Abstract][Full Text] [Related]
6. Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.
van Lier CJ; Sha J; Kirtley ML; Cao A; Tiner BL; Erova TE; Cong Y; Kozlova EV; Popov VL; Baze WB; Chopra AK
Infect Immun; 2014 Jun; 82(6):2485-503. PubMed ID: 24686064
[TBL] [Abstract][Full Text] [Related]
7. Further characterization of a highly attenuated Yersinia pestis CO92 mutant deleted for the genes encoding Braun lipoprotein and plasminogen activator protease in murine alveolar and primary human macrophages.
van Lier CJ; Tiner BL; Chauhan S; Motin VL; Fitts EC; Huante MB; Endsley JJ; Ponnusamy D; Sha J; Chopra AK
Microb Pathog; 2015 Mar; 80():27-38. PubMed ID: 25697665
[TBL] [Abstract][Full Text] [Related]
8. Deletion of Braun lipoprotein gene (lpp) and curing of plasmid pPCP1 dramatically alter the virulence of Yersinia pestis CO92 in a mouse model of pneumonic plague.
Agar SL; Sha J; Baze WB; Erova TE; Foltz SM; Suarez G; Wang S; Chopra AK
Microbiology (Reading); 2009 Oct; 155(Pt 10):3247-3259. PubMed ID: 19589835
[TBL] [Abstract][Full Text] [Related]
9. Immunisation of two rodent species with new live-attenuated mutants of
Tiner BL; Sha J; Cong Y; Kirtley ML; Andersson JA; Chopra AK
NPJ Vaccines; 2016; 1():16020. PubMed ID: 29263858
[TBL] [Abstract][Full Text] [Related]
10. Identification of New Virulence Factors and Vaccine Candidates for
Andersson JA; Sha J; Erova TE; Fitts EC; Ponnusamy D; Kozlova EV; Kirtley ML; Chopra AK
Front Cell Infect Microbiol; 2017; 7():448. PubMed ID: 29090192
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.
Erova TE; Rosenzweig JA; Sha J; Suarez G; Sierra JC; Kirtley ML; van Lier CJ; Telepnev MV; Motin VL; Chopra AK
Clin Vaccine Immunol; 2013 Feb; 20(2):227-38. PubMed ID: 23239803
[TBL] [Abstract][Full Text] [Related]
12. Deletion of Braun lipoprotein gene (lpp) attenuates Yersinia pestis KIM/D27 strain: role of Lpp in modulating host immune response, NF-kappaB activation and cell death.
Liu T; Agar SL; Sha J; Chopra AK
Microb Pathog; 2010 Jan; 48(1):42-52. PubMed ID: 19737605
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK
mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks.
Sha J; Endsley JJ; Kirtley ML; Foltz SM; Huante MB; Erova TE; Kozlova EV; Popov VL; Yeager LA; Zudina IV; Motin VL; Peterson JW; DeBord KL; Chopra AK
J Clin Microbiol; 2011 May; 49(5):1708-15. PubMed ID: 21367990
[TBL] [Abstract][Full Text] [Related]
15. Outer membrane protein X (Ail) contributes to Yersinia pestis virulence in pneumonic plague and its activity is dependent on the lipopolysaccharide core length.
Kolodziejek AM; Schnider DR; Rohde HN; Wojtowicz AJ; Bohach GA; Minnich SA; Hovde CJ
Infect Immun; 2010 Dec; 78(12):5233-43. PubMed ID: 20837715
[TBL] [Abstract][Full Text] [Related]
16. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
[TBL] [Abstract][Full Text] [Related]
17. A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague.
Sha J; Rosenzweig JA; Kirtley ML; van Lier CJ; Fitts EC; Kozlova EV; Erova TE; Tiner BL; Chopra AK
Microb Pathog; 2013 Feb; 55():39-50. PubMed ID: 23063826
[TBL] [Abstract][Full Text] [Related]
18. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
Derbise A; Cerdà Marín A; Ave P; Blisnick T; Huerre M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2012; 6(2):e1528. PubMed ID: 22348169
[TBL] [Abstract][Full Text] [Related]
19. Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.
Sun W; Roland KL; Kuang X; Branger CG; Curtiss R
Infect Immun; 2010 Mar; 78(3):1304-13. PubMed ID: 20086087
[TBL] [Abstract][Full Text] [Related]
20. The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis.
Bozue J; Mou S; Moody KL; Cote CK; Trevino S; Fritz D; Worsham P
Microb Pathog; 2011 Jun; 50(6):314-21. PubMed ID: 21320584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
